Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tivantinib monotherapy in advanced gastric cancer
NCT01152645Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Jun 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of tivantinib in gastric cancer (GC), sponsored by Kyowa Kirin. Primary endpoint: Disease Control. Started Jun 2010; status: completed.
02
Drugs
tivantinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01152645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01152645.